1. Azi LMTA, Fonseca NM, Linard LG. SBA 2020: regional anesthesia safety recommendations update. Braz J Anesthesiol. 2020;70(4):398-418. doi: 10.1016/j.bjan.2020.02.005
2. Provenzano DA, Hanes M, Hunt C, et al. ASRA Pain Medicine consensus practice infection control guidelines for regional anesthesia and pain medicine. Reg Anesth Pain Med. 2025. doi: 10.1136/rapm-2024-105651
3. Johnson SM, Saint John BE, Dine AP. Local anesthetics as antimicrobial agents: a review. Surg Infect (Larchmt). 2008;9(2):205-213. doi: 10.1089/sur.2007.036
4. Heller S, Seemann RJ, Burgkart R, Obermeier A, Locher H. Lidocaine shows significant antimicrobial effects against Staphylococcus aureus, MRSA, and Staphylococcus epidermidis. Biomedicines. 2025;13(1):106. doi: 10.3390/biomedicines13010106
5. Lee JS, Moon J, Lee JY, et al. Antibacterial activity of local anesthetics against multidrug-resistant bacteria. Microorganisms. 2025;17(6):4774-4778. doi: 10.62347/GKXF8390
6. Sakuragi T, Ishino H, Dan K. Bactericidal activity of clinically used local anes-thetics on Staphylococcus aureus. Reg Anesth. 1996;21(3):239-242. doi: 10.1136/rapm-00115550-199621030-00011
7. Ohsuka S, Ohta M, Masuda K, Arakawa Y, Kaneda T, Kato N. Lidocaine hydro-chloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol Immunol. 1994;38(6):429-434. doi: 10.1111/j.1348-0421.1994.tb01803.x
8. Faustova M, Nazarchuk O, Dmytriiev D, Babina Y, Nazarchuk H, Dudar A. The effect of local anesthetics against planktonic forms and biofilm formation of Staphylococcus aureus clinical strains. Front Microbiol. 2023;14:1199899. doi: 10.3389/fmicb.2023.1199899
9. Tuon FF, Suss PH, Telles JP, Dantas LR, Borges NH, Ribeiro VST. Antimicrobial treatment and pathogenesis of Staphylococcus aureus biofilm-associated infections. Pathogens. 2023;12(1):87-102. doi: 10.3390/antibiotics12010087
10. Hodson M, Gajraj R, Scott NB. A comparison of the antibacterial activity of levo-bupivacaine vs. bupivacaine: an in vitro study with bacteria implicated in epidural infection. Anaesthesia. 1999;54(7):699-702. doi: 10.1046/j.1365-2044.1999.00742.x
11. Guillier M, Boselli E, Bouvet L, et al. Levobupivacaine hydrochloride and sufentanil have no antimicrobial effect at 25°C in vitro. Eur J Anaesthesiol. 2007;24(7):634-639. doi: 10.1017/S0265021507000026
12. Coghlan MW, Davies MJ, Hoyt C, Joyce L, Kilner R, Waters MJ. Antibacterial activity of epidural infusions. Anaesth Intensive Care. 2009;37(1):66-69.
13. Aydin ON, Eyigor M, Aydin N. Antimicrobial activity of lidocaine and bupivacaine on wound pathogens. Anaesthesia. 2001;18(10):687-694. doi: 10.1046/j.1365-2346.2001.00900.x
14. Feldman JM, Chapin-Robertson K, Turner J. Do agents used for epidural analgesia have antimicrobial properties? Reg Anesth. 1994;19(1):43-47.